A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta
about
Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetesIncreased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupusPreliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report.In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in miceCD8+ Tregs in lupus, autoimmunity, and beyond.The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus.The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study.A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.Possible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue.Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study.Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome.Cytokines in systemic lupus erythematosusInduction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone miceInduction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupusUpdate on emerging drug therapies for systemic lupus erythematosus.Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.Regulatory T-cell-associated cytokines in systemic lupus erythematosus.In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity.Nanomaterials, Autophagy, and Lupus Disease.T-cell-directed therapies in systemic lupus erythematosus.Antigen-specific immunotherapies in rheumatic diseases.Bcl-xL affects the development of functional CD4 Tregs.Procainamide-induced autoimmunity: Relationship to T-helper 2-type T-cell activation.Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of actionImmunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience
P2860
Q24627149-2F134E3F-7AEF-4293-99F9-59382E753F11Q28507270-DFE3BCC8-00D1-4EA4-BAF4-8FA529A013DEQ31069812-CB071423-70A1-4D6B-BA0F-B4E759A8688BQ33521228-C8EFA221-709D-4287-8243-D0A85C951F79Q33889097-C2E8C37F-ADC2-4355-99EA-EB90C2698239Q34653846-F0AAE403-D531-4C18-BFAE-8CDF8923AD8EQ35074594-B93DB953-3B91-45B2-AE4D-A77E91B708B3Q35099671-DDD77F3F-63FD-45FB-83EC-2CA1CA54D147Q35722274-BB89AC45-3BFE-486C-BB64-41EB7BD50532Q35762291-A3DBFB66-6E38-4C2D-A013-06DB7B24A32BQ35960478-95EBB894-012C-46C5-80AF-A4607ACB415FQ36298357-05F20F05-70A1-4C52-94A8-271CD1B4B642Q36659210-94605935-CA47-47CA-851E-FCC3B7E76F98Q37052040-CE8D857F-47B8-479D-8432-6571B3CAD6BEQ37120570-772ADF46-5FE6-4B59-B962-C418C09CC61EQ37361089-58865B4A-4618-42EE-981D-975A7684C1A5Q37444305-A2B58B58-6DCF-4EE4-9784-C2EA27BCB732Q37690745-08339107-7441-4778-816A-6D2B7EADB29BQ37773268-B9544BEF-7C0E-4A4B-8A5C-A7131BAF636AQ37973328-2E3C809B-BED8-4D66-820D-DB5F855E1FA2Q38039963-A1142A8E-9439-48B5-9519-6B324C80E027Q38551098-52666C71-4030-4544-A480-3E32C24951B4Q38920440-14A18DEC-A9F3-43A1-AB66-5F7938D0B259Q39431371-A1425D5B-AF0B-4C68-AACF-AFC73AABA860Q42420372-3087C43D-750A-49DC-8552-28638EC6D6D0Q46331275-C55D26BE-4F09-44C2-BB29-540682E1A637Q46616003-5B0F51E4-28A5-4DFF-A771-97666B2D6FC6Q56901334-0C6BD6E2-28A2-4CA2-B8CD-25521ABCE307Q57537530-0A399EBA-38DE-43E2-99A0-A82755EF3F19
P2860
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@ast
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@en
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@nl
type
label
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@ast
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@en
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@nl
prefLabel
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@ast
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@en
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@nl
P2093
P2860
P356
P1476
A peptide based on the complem ...... g CD4+CD25+ cells and TGF-beta
@en
P2093
Amir Sharabi
Edna Mozes
Heidy Zinger
Maya Zborowsky
Zev M Sthoeger
P2860
P304
P356
10.1073/PNAS.0603201103
P407
P577
2006-05-30T00:00:00Z